Table 5. Correlation analysis between downstaging and the highest individual grade by CTCAE.
| Groups within patient cohort | Spearman correlation coefficient (95% CI) | P value |
|---|---|---|
| AE-grades in entire cohort (n=261) | −0.133 (−0.245 to −0.020) | 0.033* |
| AE-grades in cohort all pre-planned NAC-cycles (n=200) | −0.148 (−0.283 to −0.016) | 0.038** |
| AE-grades in cohort NAC-cycles <3 (n=61) | −0.021 (−0.281 to 0.218) | 0.874 |
*, when AE grade decrease, downstaging will increase (in entire cohort). **, when AE grade decrease, downstaging will increase (in cohort who received all pre-planned). CTCAE, Common Terminology Criteria for Adverse Events; AE, adverse event; NAC, neoadjuvant chemotherapy; CI, confidence interval.